P1123 RESPONSE-GUIDED THERAPY WITH BOCEPREVIR PLUS PEGINTERFERON ALFA-2a (40KD) AND RIBAVIRIN IN TREATMENT-NAIVE PATIENTS INFECTED WITH HCV GENOTYPE 1: INTERIM RESULTS FROM THE TriCo STUDY
Ferenci, P., Flisiak, R., Caruntu, F.A., Lengyel, G., Hohmann, M., Bakalos, G.Volume:
60
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(14)61283-6
Date:
April, 2014
File:
PDF, 92 KB
english, 2014